AAA
MRTX

Affinity Asset Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Affinity Asset Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$5.88M Buy
2023
Q3 		$2.63M Buy
2022
Q1 		– Sell
2021
Q4 		$2.93M Sell
2021
Q3 		$4.87M Buy
2021
Q1 		– Sell
2020
Q4 		$2.2M Buy